Question 1

What are the most cited papers from PYC Therapeutics (Australia)?

Accepted Answer

The most cited paper from PYC Therapeutics (Australia) is "Screening for peptide drugs from the natural repertoire of biodiverse protein folds" (Paul M. Watt, 2006), with 117 citations. Next come "Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease" (103) and "Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers" (84).

Question 2

Which research topics does PYC Therapeutics (Australia) publish most on?

Accepted Answer

By volume in 2022-now: Genetic and Kidney Cyst Diseases, RNA Interference and Gene Delivery, Extracellular vesicles in disease and Pluripotent Stem Cells Research.

Question 3

Which keywords describe research at PYC Therapeutics (Australia)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Cancer, Transcriptional Regulation, Gene Therapy, Tumor Microenvironment, Stromal Cells, Epigenetic Regulation and Cell Proliferation.

Question 4

Which fields of science does PYC Therapeutics (Australia) work in?

Accepted Answer

In all years, 37% of research at PYC Therapeutics (Australia) is in Life Sciences, 29% in Health Sciences. Its largest fields are Medicine (27%), Biochemistry, Genetics and Molecular Biology (26%), Engineering (9%). It does 2.0× the world's share of Life Sciences.

Question 5

Is PYC Therapeutics (Australia)'s research output growing?

Accepted Answer

Output in 2022-2025 was 69% higher than in 2018-2021.